TY  - JOUR

T1  - Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial

JO  - Acta Dermato-Venereologica

UR  - http://dx.doi.org/10.2340/actadv.v104.13467

PY  - 2024/02/12

AU  - Cork MJ

AU  - Lockshin B

AU  - Pinter A

AU  - Chen Z

AU  - Shumel B

AU  - Prescilla R

ED  - 

DO  - DOI: 10.2340/actadv.v104.13467

PB  - MJS Publishing, Medical Journals Sweden AB

VL  - 104

SP  - adv13467

EP  - adv13467

Y2  - 2024/12/22

ER  -